Cargando…
A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers
BACKGROUND: Given the limited supply of two COVID-19 vaccines, it will be important to choose which risk groups to prioritize for vaccination in order to get the most health benefits from that supply. METHOD: In order to help decide how to get the maximum health yield from this limited supply, we im...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781339/ https://www.ncbi.nlm.nih.gov/pubmed/33398296 http://dx.doi.org/10.1101/2020.12.18.20248504 |
_version_ | 1783631657083863040 |
---|---|
author | McDonald, Clement J. Baik, Seo H. Zheng, Zhaonian Amos, Liz |
author_facet | McDonald, Clement J. Baik, Seo H. Zheng, Zhaonian Amos, Liz |
author_sort | McDonald, Clement J. |
collection | PubMed |
description | BACKGROUND: Given the limited supply of two COVID-19 vaccines, it will be important to choose which risk groups to prioritize for vaccination in order to get the most health benefits from that supply. METHOD: In order to help decide how to get the maximum health yield from this limited supply, we implemented a logistic regression model to predict COVID-19 death risk by age, race, and sex and did the same to predict COVID-19 case risk. RESULTS: Our predictive model ranked all demographic groups by COVID-19 death risk. It was highly concentrated in some demographic groups, e.g. 85+ year old Black, Non-Hispanic patients suffered 1,953 deaths per 100,000. If we vaccinated the 17 demographic groups at highest COVID-19 death ranked by our logistic model, it would require only 3.7% of the vaccine supply needed to vaccinate all the United States, and yet prevent 47% of COVID-19 deaths. Nursing home residents had a higher COVID-19 death risk at 5,200 deaths/100,000, more than our highest demographic risk group. Risk of prison residents and health care workers (HCW) were lower than that of our demographic groups with the highest risks. We saw much less concentration of COVID-19 case risk in any demographic groups compared to the high concentration of COVID-19 death in some such groups. We should prioritize vaccinations with the goal of reducing deaths, not cases, while the vaccine supply is low. CONCLUSION: SARS-CoV-2 vaccines protect against severe COVID-19 infection and thus against COVID-19 death per vaccine studies. Allocating at least some of the early vaccine supplies to high risk demographic groups could maximize lives saved. Our model, and the risk estimate it produced, could help states define their vaccine allocation rules. |
format | Online Article Text |
id | pubmed-7781339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-77813392021-01-05 A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers McDonald, Clement J. Baik, Seo H. Zheng, Zhaonian Amos, Liz medRxiv Article BACKGROUND: Given the limited supply of two COVID-19 vaccines, it will be important to choose which risk groups to prioritize for vaccination in order to get the most health benefits from that supply. METHOD: In order to help decide how to get the maximum health yield from this limited supply, we implemented a logistic regression model to predict COVID-19 death risk by age, race, and sex and did the same to predict COVID-19 case risk. RESULTS: Our predictive model ranked all demographic groups by COVID-19 death risk. It was highly concentrated in some demographic groups, e.g. 85+ year old Black, Non-Hispanic patients suffered 1,953 deaths per 100,000. If we vaccinated the 17 demographic groups at highest COVID-19 death ranked by our logistic model, it would require only 3.7% of the vaccine supply needed to vaccinate all the United States, and yet prevent 47% of COVID-19 deaths. Nursing home residents had a higher COVID-19 death risk at 5,200 deaths/100,000, more than our highest demographic risk group. Risk of prison residents and health care workers (HCW) were lower than that of our demographic groups with the highest risks. We saw much less concentration of COVID-19 case risk in any demographic groups compared to the high concentration of COVID-19 death in some such groups. We should prioritize vaccinations with the goal of reducing deaths, not cases, while the vaccine supply is low. CONCLUSION: SARS-CoV-2 vaccines protect against severe COVID-19 infection and thus against COVID-19 death per vaccine studies. Allocating at least some of the early vaccine supplies to high risk demographic groups could maximize lives saved. Our model, and the risk estimate it produced, could help states define their vaccine allocation rules. Cold Spring Harbor Laboratory 2020-12-24 /pmc/articles/PMC7781339/ /pubmed/33398296 http://dx.doi.org/10.1101/2020.12.18.20248504 Text en https://creativecommons.org/publicdomain/zero/1.0/This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license (https://creativecommons.org/publicdomain/zero/1.0/) . |
spellingShingle | Article McDonald, Clement J. Baik, Seo H. Zheng, Zhaonian Amos, Liz A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers |
title | A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers |
title_full | A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers |
title_fullStr | A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers |
title_full_unstemmed | A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers |
title_short | A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers |
title_sort | method for prioritizing risk groups for early sars-cov-2 vaccination, by the numbers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781339/ https://www.ncbi.nlm.nih.gov/pubmed/33398296 http://dx.doi.org/10.1101/2020.12.18.20248504 |
work_keys_str_mv | AT mcdonaldclementj amethodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers AT baikseoh amethodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers AT zhengzhaonian amethodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers AT amosliz amethodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers AT mcdonaldclementj methodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers AT baikseoh methodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers AT zhengzhaonian methodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers AT amosliz methodforprioritizingriskgroupsforearlysarscov2vaccinationbythenumbers |